The G20210A prothrombin polymorphism is not associated with increased thromboembolic risk in a large protein C deficient kindred

Thrombosis and Haemostasis

Volumn 83, Issue 3, 2000, Pages 366-370

  Bovill, Edwin G ^a   Hasstedt, Sandra J ^b   Callas, Peter W ^d   Valliere, Julia E ^a   Scott, Bruce T ^a   Bauer, Kenneth A ^c   Long, George L ^a  

^a UNIVERSITY OF VERMONT   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^c HARVARD UNIVERSITY   (United States)

^d NONE

Author keywords

G20210A prothrombin variant; Hereditary; Protein C deficiency; Thrombophilia; Thrombosis

Indexed keywords

BLOOD CLOTTING FACTOR 5 LEIDEN; PROTEIN C; PROTHROMBIN;

ARTICLE; CANADA; GENE LINKAGE DISEQUILIBRIUM; GENE MUTATION; GENETIC POLYMORPHISM; GENOTYPE; HETEROZYGOTE; HOMOZYGOTE; HUMAN; MAJOR CLINICAL STUDY; PEDIGREE; PRIORITY JOURNAL; PROTEIN C DEFICIENCY; RISK FACTOR; THROMBOEMBOLISM;

EID: 0034061809     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1613822     Document Type: Article

References (32)

1. Lane DA, Mannucci PM, Bauer KA, Bertina RM, Bochkov NP, Boulyjenkov V, Chandy M, Dahlback B, Ginler EK, Miletich JP, Rosendaal FR, Seligsohn U: Inherited Thrombophilia: Part 1. Thromh Haemost 1996; 76: 651-2.
2. Bertina RM, Koeleman BPC, Koster T, Rosendaal FR, Dirven RJ, de Ronde H, van der Velden PA, Reitsna PH: Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature. 1994; 369: 64-7.
3. Poort SR, Rosendaal FR, Reitsma PH, Bertina RM: A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 1996; 88: 3698.
4. Seligsohn U, Berger A, Abend, Rubin L, Attias D, Zivelin A, Rapaport SI: Homozygous protein C deficiency manifested by massive venous thrombosis in the newborn. N Engl J Med 1984; 310: 559.
5. Mahasandana C, Suvatte V, Chuansumrit AS, Marlar RA, Manco-Johnson, MJ, Jacobson LJ, Hathaway WE: Homozygous protein S deficiency in an infant with purpura fulmination. J Pediatr 1990; 117: 750.
6. Kyrle PA, Mannhalter C, Beguin S, Stumpflen A, Hirsschl M, Weltermann A. Stain M. Brenner B, Speiser W, Pabinger I, Lechner K, Eichinger S: Clinical studies and thrombin generation in patients homozygous or heterozygous for the G20210A mutation in the prothromhin gene. Arterioscler Thromc Vasc Biol 1998; 18: 1287.
7. Rosendahl FR, Koster T, Vandenbroucke JP, et al: High Risk of thrombosis in individuals homozygous for factor V Leidin (activated protein C resistance). Blood 1995; 85:1504-8.
8. Bovill EG, Bauer KA, Dickerman JD, Callas P, West B: The clinical spectrum of heterozygous protein C deficiency in a large New England kindred. Blood 1989; 73: 712.
9. Seligsohn U, Zivelin A: Thrombophilia as a multigenic disorder. Thromb Haemost 1997; 78: 297.
10. Koeleman BPC, Reitsma PH, Allaart CF, Bertina RM: Activated protein C resistance as an additional risk factor for thrombosis in protein C-deficient families. Blood 1995; 84: 1031.
11. Zoller B, Berntsdotter A, de Grutos PG, Dahlback B: Resistance to activated protein C as an additional genetic risk factor in hereditary deficiency of protein S. Blood 1995; 85: 3518.
12. Van Boven HH, Reitsma PH, Rosendahl FR, Bayston TA, Chowdhury V, Bauer KA, Scharrer I, Conard J, Lane DA: Factor V Leiden (FV R506Q) in families with inherited antithrombin deficiency. Thromb Haemost 1996; 75: 417.
13. Zoller B, Svensson PJ, Dahlback B, Hillarp A: The A20210 allele of the prothrombin gene is frequently associated with the factor V Arg 506 to Gln mutation but not with protein S deficiency in thrombophilic families (letter). Blood 1998; 91: 2210.
14. Conard J, Mabileau-Brouzes C, Horellou MH, Elalamy I, Samama MM: Multigenic thrombophilia: genetic anomaly of factor II and mutation of factor V Leiden. Study in a French family. Presse Medicale 1997; 26: 951.
15. Ehrenforth S, Ludwig G, Klinke S, Krause M, Scharrer I, Nowak-Gottl U: The prothrombin 20210 A allele is frequently coinherited in young carriers of the factor V Arg 506 to Gln mutation with venous thrombophilia (letter). Blood 1998; 91: 2209.
16. Makris M, Preston FE, Beauchamp NJ, Cooper PC, Daly ME, Hampton KK, Bayliss P, Peake IR, Miller GJ: Co-inheritance of the 20210A allele of the prothrombin gene increases the risk of thrombosis in subjects with familial thrombophilia. Thromb Haemost 1997; 78: 1426.
17. Tomczak JA, Ando RA, Sobel HG, Bovill EG, Long GL: Genetic analysis of a large kindred exhibiting type I protein C deficiency and associated thrombosis. Thromb Res 1994; 74: 243.
18. Hasstedt SJ, Bovill EG, Callas PW, Long GL: An unknown genetic defect increases venous thrombosis risk, through interaction with protein C deficiency. Am J Hum Genet 1998; 63: 569.
19. Teitel JM, Bauer KA, Lau HK, Rosenberg RD: Studies of the prothrombin activation pathway utilizing radioimmunoassays for the F2/F1.2 fragment and thrombin-antithrombin complex. Blood 1982; 59: 1086.
20. Elston RC, Stewart J: A general model for the genetic analysis of pedigree data. Hum Hered 1971; 21: 523.
21. Hasstedt SJ, PAP: Pedigree Analysis Package, rev 5. Department of Human Genetics, University of Utah, Salt Lake City, UT, 1998
22. Gill PE, Murra, Saunders MA, Wright MH: A fortran package for nonlinear programming. Tech rep SOL 86-2, Department of Operations Research, Stanford University. Stanford, California, 1986.
23. Spielman RD, Ewens WJ: The TDT and other Family-based tests for linkage disequilibrium and association. Am J Hum Genet 1996; 59, 983.
24. Spielman RS, McGinnis RE, Ewens WJ: Transmission test for linkage disequilibrium: The insulin gene region and insulin-dependent diabetes mellitus (IDDM). Am J Hum Genet 1993; 52: 506-16.
25. Hasstedt SJ: The transmission/disequilibrium test by computing likelihoods on pedigrees. In press, Genet Epidemiol, 1999.
26. Boerwinkle E, Chakrabony R, Sing CF: The use of measured genotype information in the analysis of quantitative phenotypes in man. I. Models and analytical methods. Ann Hum Genet 1986; 50:181.
27. Miletich J, Sherman L, Broze G: Absence of thrombosis in subjects with heterozygous protein C deficiency. N Engl J Med 1987; 317:991.
28. Cumming AM, Keeney S, Salden A, Bhavnani M, Shwe KH, Hay CR: The prothrombin gene G20210A variant: prevalence in a U.K. anticoagulant clinic population. Br J Haematol 1997; 98: 353.
29. Lensen RPM, Rosendaal FR, Koster T, Allaart CF, deRonde H, Vandenbroucke JP, Reitsma PH, Bertina RM: Apparent different thrombotic tendency in patients with factor V Leiden and protein C deficiency due to selection of patients. Blood 1996; 88:4205.
30. Scott BT, Bovill EG, Valliere JE, Leppert MF, Hasstedt SJ, Varvil TS, Callas PW, Long GL: Genetic linkage analysis for cosegregating candidate genes associated with thrombosis in a large protein C deficient kindred. Blood (abstract) 1998; 92:758.
31. Ress DC, Cox M, Clegg JB: World distribution of factor V Leiden. Lancet 1995; 346:1133-4.
32. Miletich JP, Prescott SM, White R, Majerus PW, Bovill EG: Inherited predisposition to thrombosis (Review) Cell 1993; 72: 477.